Journal of Stroke

metrics 2024

Connecting Researchers and Clinicians for Stroke Progress

Introduction

Journal of Stroke is a premier open-access journal published by the Korean Stroke Society, dedicated to advancing the understanding of stroke through cutting-edge research and innovative clinical practices. Since its inception in 2013, the journal has gained notable recognition in the fields of Cardiology and Cardiovascular Medicine and Neurology, reflecting its commitment to high-quality, peer-reviewed content, with rankings in the top quartiles (Q1) for both categories as of 2023. The journal’s impact is underscored by its Scopus rankings, placing it in the 92nd and 91st percentiles within its respective fields, thus serving as a vital resource for researchers, clinicians, and students seeking to enhance their knowledge and contribute to stroke research and treatment methodologies. The Journal of Stroke is strategically positioned in South Korea and fosters a global dialogue on stroke-related issues, reinforcing its role as a pivotal platform for disseminating vital findings that can influence both clinical practices and health policy.

Metrics 2024

SCIMAGO Journal Rank1.84
Journal Impact Factor6.00
Journal Impact Factor (5 years)7.00
H-Index48
Journal IF Without Self6.00
Eigen Factor0.00
Normal Eigen Factor0.66
Influence2.35
Immediacy Index2.90
Cited Half Life5.60
Citing Half Life6.30
JCI1.44
Total Documents435
WOS Total Citations2201
SCIMAGO Total Citations5008
SCIMAGO SELF Citations172
Scopus Journal Rank1.84
Cites / Document (2 Years)4.16
Cites / Document (3 Years)4.53
Cites / Document (4 Years)4.77

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #30/387
Percentile 92.25
Quartile Q1
Neurology (clinical) in Medicine
Rank #33/400
Percentile 91.75
Quartile Q1

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 23/277
Percentile 91.90
Quartile Q1
PERIPHERAL VASCULAR DISEASE
Rank 8/96
Percentile 92.20
Quartile Q1

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 31/278
Percentile 88.85
Quartile Q1
PERIPHERAL VASCULAR DISEASE
Rank 10/96
Percentile 89.58
Quartile Q1

Quartile History

Similar Journals

JAMA Neurology

Exploring Innovations in Neurological Disorders
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Stroke-Vascular and Interventional Neurology

Pioneering the future of stroke and interventional neurology.
Publisher: WILEYISSN: 2694-5746Frequency: 6 issues/year

Stroke-Vascular and Interventional Neurology, published by WILEY, is a leading open-access journal dedicated to advancing the field of neurology with a particular focus on stroke and vascular interventions. Since its inception in 2021 as an open-access journal, it has fostered a collaborative environment for researchers, clinicians, and educators to share innovative findings and clinical practices that address the complexities of cerebrovascular diseases. The journal emphasizes high-quality, peer-reviewed research articles, reviews, and case studies, providing critical insights into cutting-edge therapies and surgical techniques. With an ISSN of 2694-5746, it aims to support the global medical community in improving the diagnosis, treatment, and overall management of stroke patients. Researchers and healthcare professionals benefit from its accessible content, which is vital for fostering comprehensive understanding and evidence-based practices within the realm of interventional neurology.

NEUROLOGY

Shaping the future of neurology through rigorous research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

European Stroke Journal

Transforming knowledge into stroke prevention strategies.
Publisher: SAGE PUBLICATIONS LTDISSN: 2396-9873Frequency: 4 issues/year

The European Stroke Journal, published by SAGE Publications Ltd, is a pivotal resource in the domains of Cardiology and Neurology, reflecting its commitment to advancing knowledge and research in these critical areas of medicine. Since its inception in 2016, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in both Cardiology and Neurology (clinical) as of 2023, placing it among the top quartile publications in these fields. With a prominent position, ranked 65th and 72nd respectively in Scopus for Cardiology and Neurology, the journal caters to a diverse audience of researchers, clinicians, and students dedicated to improving stroke treatment and prevention strategies. Although it operates under a traditional access model, its impactful publications are essential for anyone involved in stroke research, ensuring they remain at the forefront of scientific developments and clinical practices.

ESC Heart Failure

Elevating the understanding of heart failure management.
Publisher: WILEY PERIODICALS, INCISSN: 2055-5822Frequency: 6 issues/year

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

ARYA Atherosclerosis

Championing transparency and accessibility in cardiology.
Publisher: ISFAHAN UNIV MEDICAL SCIENCES, ISFAHAN CARDIOVASCULAR RES CENTERISSN: 1735-3955Frequency: 4 issues/year

ARYA Atherosclerosis is a distinguished open-access journal published by Isfahan University of Medical Sciences and the Isfahan Cardiovascular Research Center, with an ISSN of 1735-3955 and an E-ISSN of 2251-6638. Founded in 2005, this journal seeks to advance the field of cardiology and cardiovascular medicine by providing a platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings related to atherosclerosis and its implications for cardiovascular health. Although currently ranked in Q4 of its category in 2023, ARYA Atherosclerosis plays a vital role in the academic community by promoting open access to vital research, fostering collaboration, and encouraging the sharing of knowledge. The journal's commitment to transparency and accessibility makes it an essential resource for those looking to stay informed about the latest developments in cardiovascular research. Based in Iran, it is positioned within an emerging research landscape that is increasingly contributing to global health discussions.

Topics in Stroke Rehabilitation

Enhancing lives with cutting-edge insights.
Publisher: TAYLOR & FRANCIS LTDISSN: 1074-9357Frequency: 6 issues/year

Topics in Stroke Rehabilitation, published by Taylor & Francis Ltd, stands as a premier academic journal offering cutting-edge research and insights in the fields of rehabilitation, neurology, and community care. With an impressive impact factor reflecting its strong scholarly influence, this journal not only maintains a distinguished Q1 ranking in Community and Home Care and Rehabilitation but is also recognized in the Q2 category for Clinical Neurology, showcasing its relevance across multiple disciplines. Covering a comprehensive range of topics from neurorehabilitation techniques to patient-centered care strategies, Topics in Stroke Rehabilitation serves as an essential resource for researchers, healthcare professionals, and students dedicated to enhancing the quality of life for individuals recovering from stroke. With an accessible archive dating back to 1996 and continuous publication through 2024, this journal invites collaboration and discourse, fostering advancements in both theoretical knowledge and practical applications within the realm of stroke rehabilitation.

Cardiology Journal

Unleashing insights for better heart health.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Acta Epileptologica

Fostering collaboration in the fight against epilepsy.
Publisher: SPRINGERNATUREISSN: 2096-9384Frequency: 1 issue/year

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

Cerebrovascular Diseases Extra

Amplifying Research Impact in Neurology and Cardiology
Publisher: KARGERISSN: 1664-5456Frequency: 3 issues/year

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.